Advancing Heart Failure Research Through Innovative Clinical Trial Design

 

Cardiovascular disease remains public enemy number one in healthcare. Taking the top spot on the mortality scale, diseases of the heart are predicted to affect nearly 10 million people over the age of 18 by 2020 – a 25 per cent increase in just a decade.1 Karen Hill, Senior Vice President, Project Management, Cardiovascular and Metabolic Diseases, and Nancy Newark, Executive Director, Project Management, Cardiovascular and Metabolic Diseases, discuss how innovation in heart failure clinical trials can advance research programs in the latest Journal for Clinical Studies article.

  

Want the PDF version?

 
  (Click on the images to zoom in)

 

Advancing Heart Failure Research Page 1

Advancing Heart Failure Research Page 2

 

Have questions about an upcoming trial?